BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

333 related articles for article (PubMed ID: 22773549)

  • 1. Heterogeneity in mouse spasmolytic polypeptide-expressing metaplasia lineages identifies markers of metaplastic progression.
    Weis VG; Sousa JF; LaFleur BJ; Nam KT; Weis JA; Finke PE; Ameen NA; Fox JG; Goldenring JR
    Gut; 2013 Sep; 62(9):1270-9. PubMed ID: 22773549
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Macrophages promote progression of spasmolytic polypeptide-expressing metaplasia after acute loss of parietal cells.
    Petersen CP; Weis VG; Nam KT; Sousa JF; Fingleton B; Goldenring JR
    Gastroenterology; 2014 Jun; 146(7):1727-38.e8. PubMed ID: 24534633
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A molecular signature of gastric metaplasia arising in response to acute parietal cell loss.
    Nozaki K; Ogawa M; Williams JA; Lafleur BJ; Ng V; Drapkin RI; Mills JC; Konieczny SF; Nomura S; Goldenring JR
    Gastroenterology; 2008 Feb; 134(2):511-22. PubMed ID: 18242217
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Spasmolytic polypeptide-expressing metaplasia (SPEM) in the gastric oxyntic mucosa does not arise from Lgr5-expressing cells.
    Nam KT; O'Neal RL; Coffey RJ; Finke PE; Barker N; Goldenring JR
    Gut; 2012 Dec; 61(12):1678-85. PubMed ID: 22198711
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and potential therapeutic mechanism of Weiwei decoction on Spasmolytic polypeptide-expressing metaplasia in Helicobacter pylori-infected and Atp4a-knockout mice.
    Hong X; Li H; Lin Y; Luo L; Xu W; Kang J; Li J; Huang B; Xu Y; Pan H; Guo S
    J Ethnopharmacol; 2024 Jan; 319(Pt 1):117062. PubMed ID: 37598768
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Spasmolytic polypeptide expressing metaplasia to preneoplasia in H. felis-infected mice.
    Nomura S; Baxter T; Yamaguchi H; Leys C; Vartapetian AB; Fox JG; Lee JR; Wang TC; Goldenring JR
    Gastroenterology; 2004 Aug; 127(2):582-94. PubMed ID: 15300590
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mature chief cells are cryptic progenitors for metaplasia in the stomach.
    Nam KT; Lee HJ; Sousa JF; Weis VG; O'Neal RL; Finke PE; Romero-Gallo J; Shi G; Mills JC; Peek RM; Konieczny SF; Goldenring JR
    Gastroenterology; 2010 Dec; 139(6):2028-2037.e9. PubMed ID: 20854822
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of progressive metaplasia in the gastric corpus mucosa of Mongolian gerbils infected with Helicobacter pylori.
    Shimizu T; Choi E; Petersen CP; Noto JM; Romero-Gallo J; Piazuelo MB; Washington MK; Peek RM; Goldenring JR
    J Pathol; 2016 Aug; 239(4):399-410. PubMed ID: 27125972
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current understanding of SPEM and its standing in the preneoplastic process.
    Weis VG; Goldenring JR
    Gastric Cancer; 2009; 12(4):189-97. PubMed ID: 20047123
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Single-Cell Transcriptional Analyses Identify Lineage-Specific Epithelial Responses to Inflammation and Metaplastic Development in the Gastric Corpus.
    Bockerstett KA; Lewis SA; Noto CN; Ford EL; Saenz JB; Jackson NM; Ahn TH; Mills JC; DiPaolo RJ
    Gastroenterology; 2020 Dec; 159(6):2116-2129.e4. PubMed ID: 32835664
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amphiregulin-deficient mice develop spasmolytic polypeptide expressing metaplasia and intestinal metaplasia.
    Nam KT; Lee HJ; Mok H; Romero-Gallo J; Crowe JE; Peek RM; Goldenring JR
    Gastroenterology; 2009 Apr; 136(4):1288-96. PubMed ID: 19230855
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Injury, repair, inflammation and metaplasia in the stomach.
    Meyer AR; Goldenring JR
    J Physiol; 2018 Sep; 596(17):3861-3867. PubMed ID: 29427515
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Maturity and age influence chief cell ability to transdifferentiate into metaplasia.
    Weis VG; Petersen CP; Weis JA; Meyer AR; Choi E; Mills JC; Goldenring JR
    Am J Physiol Gastrointest Liver Physiol; 2017 Jan; 312(1):G67-G76. PubMed ID: 27881402
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potentiation of oxyntic atrophy-induced gastric metaplasia in amphiregulin-deficient mice.
    Nam KT; Varro A; Coffey RJ; Goldenring JR
    Gastroenterology; 2007 May; 132(5):1804-19. PubMed ID: 17484876
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Altered metaplastic response of waved-2 EGF receptor mutant mice to acute oxyntic atrophy.
    Ogawa M; Nomura S; Varro A; Wang TC; Goldenring JR
    Am J Physiol Gastrointest Liver Physiol; 2006 Apr; 290(4):G793-804. PubMed ID: 16306133
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Up-regulation of Aquaporin 5 Defines Spasmolytic Polypeptide-Expressing Metaplasia and Progression to Incomplete Intestinal Metaplasia.
    Lee SH; Jang B; Min J; Contreras-Panta EW; Presentation KS; Delgado AG; Piazuelo MB; Choi E; Goldenring JR
    Cell Mol Gastroenterol Hepatol; 2022; 13(1):199-217. PubMed ID: 34455107
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Establishment of novel in vitro mouse chief cell and SPEM cultures identifies MAL2 as a marker of metaplasia in the stomach.
    Weis VG; Petersen CP; Mills JC; Tuma PL; Whitehead RH; Goldenring JR
    Am J Physiol Gastrointest Liver Physiol; 2014 Oct; 307(8):G777-92. PubMed ID: 25190476
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tropism for Spasmolytic Polypeptide-Expressing Metaplasia Allows Helicobacter pylori to Expand Its Intragastric Niche.
    Sáenz JB; Vargas N; Mills JC
    Gastroenterology; 2019 Jan; 156(1):160-174.e7. PubMed ID: 30287170
    [TBL] [Abstract][Full Text] [Related]  

  • 19. WFDC2 Promotes Spasmolytic Polypeptide-Expressing Metaplasia Through the Up-Regulation of IL33 in Response to Injury.
    Jeong H; Lee B; Kim KH; Cho SY; Cho Y; Park J; Lee Y; Oh Y; Hwang BR; Jang AR; Park JH; Park JH; Jeong SH; Lee D; Lee YC; Lim KM; Goldenring JR; Nam KT
    Gastroenterology; 2021 Sep; 161(3):953-967.e15. PubMed ID: 34116028
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decrease in MiR-148a Expression During Initiation of Chief Cell Transdifferentiation.
    Shimizu T; Sohn Y; Choi E; Petersen CP; Prasad N; Goldenring JR
    Cell Mol Gastroenterol Hepatol; 2020; 9(1):61-78. PubMed ID: 31473306
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.